Neurocrine Biosciences News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

11.02.16	EARNINGS SUMMARY: Details of Neurocrine Biosciences Inc Q4 Earnings Report (RTTNews)
29.10.15	EARNINGS SUMMARY: Details of Neurocrine Biosciences Inc Q3 Earnings Report (RTTNews)
21.10.15	SNTA's GALAXY-2 Dies, NBIX For The Long Haul, VKTX Moving Ahead (RTTNews)
08.10.15	Neurocrine Reports Positive Results From Phase III Kinect 3 Study Of NBI-98854 (RTTNews)
17.09.15	Rocket Lights Up AERI, GALT Awaits Data In 3Q 2016, ITCI On Fire (RTTNews)
14.08.15	ONTX Inspired, Avalanche Triggers Panic Again, NBIX Awaits Data In Q4 (RTTNews)
29.07.15	EARNINGS SUMMARY: Details of Neurocrine Biosciences Inc Q2 Earnings Report (RTTNews)
09.06.15	OCLS Gets A Facelift, NBIX Halts Trials, CBYL For The Long Haul, CMRX On Track (RTTNews)
05.05.15	Neurocrine Appoints Bill Aurora As Vice President, Medical Affairs (RTTNews)
01.04.15	DYAX Surges, RDHL Boosts Pipeline, NBIX Cuts A Deal, OCAT Working With Vision (RTTNews)
01.04.15	Neurocrine,Mitsubishi Tanabe To Develop &Commercialize VMAT2 Inhibitor NBI-98854 (RTTNews)
19.02.15	Neurocrine Biosciences Prices Public Offering Of 6.94 Mln Shares At $36/shr (RTTNews)
09.02.15	Neurocrine Biosciences Posts Wider Q4 Loss (RTTNews)
09.01.15	FOLD Unfolds, No Pain, All Gain For NBIX, VSAR Picks Up Velocity, RVNC On Watch (RTTNews)
08.01.15	AbbVie: Phase 3 Elagolix Study Shows Positive Top-Line Results (RTTNews)
03.11.14	Neurocrine Biosciences Q3 Loss Widens - Quick Facts (RTTNews)
21.10.14	NBIX For The Long Haul, RegeneRx Catches Investors' Eyes, NewLink Inks New Deal (RTTNews)
07.08.14	Neurocrine Biosciences Q2 Loss Widens (RTTNews)
23.10.13	Neurocrine Biosciences Announces Conference Call And Webcast To Present Third Quarter 2013 Financial Results (PR Newswire)
19.09.13	Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine (PR Newswire)
10.09.13	Pre-market Movers For Sept 10 (CAG, CROX, FOLD, FIVE, NBIX, CCXI, URBN, THRX) (RTTNews)
10.09.13	NBIX Craters, DHRM Gets Busy, TGTX, BLRX Compounds Get Orphan Drug Status (RTTNews)
09.09.13	Neurocrine Announces Phase IIb Results Of VMAT2 Inhibitor NBI-98854 For Treatment Of Tardive Dyskinesia (PR Newswire)
03.09.13	Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals (PR Newswire)
03.09.13	Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference (PR Newswire)
29.08.13	Neurocrine Biosciences Announces the Start of Second Phase III Study of Elagolix in Endometriosis (PR Newswire)
25.07.13	Neurocrine Biosciences Reports Second Quarter 2013 Results (PR Newswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	3’870.00	1.49 %	K V
Lonza Grp	513.60	1.14 %	K V
Swiss Re	125.25	0.20 %	K V
Holcim	88.46	0.11 %	K V
Kuehne+Nagel Int	210.40	0.00 %	K V
Logitech Intl	68.92	-1.20 %	K V
Part Grp Hldg	1’209.00	-1.47 %	K V
CieFinRichemont	118.90	-1.94 %	K V
Nestle	76.66	-1.94 %	K V
Sonova Hldg	300.40	-5.21 %	K V

mehr

30.10.24		Anleger in New York halten sich zurück: NASDAQ Composite gibt zum Handelsende nach
30.10.24		Handel in New York: NASDAQ Composite verbucht Verluste
30.10.24		Gute Stimmung in New York: NASDAQ Composite mittags fester
30.10.24		Mittwochshandel in New York: NASDAQ Composite beginnt Mittwochssitzung in der Gewinnzone
28.08.24		NASDAQ Composite-Handel aktuell: NASDAQ Composite präsentiert sich zum Handelsende leichter
28.08.24		Handel in New York: So performt der NASDAQ Composite am Mittwochnachmittag
28.08.24		Schwache Performance in New York: So steht der NASDAQ Composite aktuell
28.08.24		Schwacher Handel: NASDAQ Composite zum Handelsstart schwächer